Coverage
-
June 16, 2016
A Massachusetts federal magistrate judge recommended on Thursday that no claims be dismissed from retailer Meijer's putative class action against pharmaceutical company Ranbaxy over the allegedly unfair competitive advantage it got from securing regulatory approvals for generic drugs it was not equipped to safely produce.
1 other articles on this case.
View all »